Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Dargent M et al. [Results of norethindrone (norluten) treatment of diffusion phase breast cancer]. 1968 Bull. Acad. Natl. Med. pmid:4906712
Dysmenorrhoea unrelieved by an oral contraceptive. 1968 Practitioner pmid:4871666
Grant EC Relation between headaches from oral contraceptives and development of endometrial arterioles. 1968 Br Med J pmid:4875428
Laudańska E [Clinical results of administration of gestagens (Anovlar 21 and Lyndiol 2,5) in endometriosis]. 1968 Ginekol. Pol. pmid:4881514
Gibian H et al. Effect of particle size on biological activity of norethisterone acetate. 1968 Acta Physiol Lat Am pmid:5753386
Karasawa Y [Treatment of dysmenorrhea with a mixed preparation of norethindrone and mestranol (S-3800C)]. 1968 Sanfujinka No Jissai pmid:5755772
Schleicher EM L.E. cells after oral contraceptives. 1968 Lancet pmid:4171166
Oral contraceptives--choice of product. 1968 Br Med J pmid:4171189
Larranaga A and Kesseru E [Two years' clinical experience with norethisterone enanthate as a prolonged-action injectable contraceptive]. 1968 Ginecol Obstet (Lima) pmid:12305607
Littleton P et al. Metabolism of [14C]norgestrel in man. 1968 J. Endocrinol. pmid:5715984
Bowman JA The effect of norethindrone-mestranol on cervical mucus. 1968 Am. J. Obstet. Gynecol. pmid:5724391
Altshuler JH et al. Neurological catastrophe related to oral contraceptives. 1968 Arch. Neurol. pmid:5725158
McDonald PG The effect of a single injection of norethindrone, with or without oestrogen, on ovulation in the rat. 1968 J. Endocrinol. pmid:5751893
Schalch DS et al. Measurement of human luteinizing hormone in plasma by radioimmunoassay. 1968 J. Clin. Invest. pmid:4295312
Kamyab S et al. Metabolism of [4-14C]lynestrenol in man. 1968 J. Endocrinol. pmid:5731790
Oppo GT et al. [The mechanism of action of synthetic antiovular drugs. Experimental studies with mestranol, medroxyprogesterone and norethindrone]. 1968 Riv Ital Ginecol pmid:5740572
Niswonger JW et al. Oral contraceptives during immediate postabortal period. 1968 Obstet Gynecol pmid:5742114
Carlborg L et al. Effect of norethisterone acetate with or without ethinyl oestradiol on the sialic acid concentration and sperm receptivity of the cervical mucus. 1968 Acta Endocrinol. pmid:5757032
Caroli J and Chevrel B [Icterus due to oral contraceptives (study of the liver at the electron microscope)]. 1968 Rev Med Chir Mal Foie pmid:5742518
Giambanco V and Di Grigoli D [The synthetic estrogen-progestagens in therapy of menometrorrhagia of puberty]. 1968 Quad Clin Ostet Ginecol pmid:5744195
Zanartu J A new approach to fertility control: long-acting injectable progesterones. 1968 Adv Fertil Control pmid:12255478
McCormick WG et al. Urinary FSH and LH excretion following combined treatment with norethisterone acetate and ethinyl oestradiol and norethisterone acetate only. 1968 Acta Endocrinol. pmid:5695269
Mestman JH et al. Adrenal-pituitary responsiveness during therapy with an oral contraceptive. 1968 Obstet Gynecol pmid:4295678
Somayaji BN et al. Norethisterone jaundice in two sisters. 1968 Br Med J pmid:4296504
Usher DR The influence of norethindrone and mestranol on pituitary-adrenal function. 1968 Can. J. Physiol. Pharmacol. pmid:4299246
Kourides IA and Kistner RW Three new synthetic progestins in the treatment of endometriosis. 1968 Obstet Gynecol pmid:5760239
Di Paola G et al. Oral contraceptives and carbohydrate metabolism. 1968 Am. J. Obstet. Gynecol. pmid:4172445
DiSaia PJ et al. Continuous tablet therapy for oral contraception. 1968 Obstet Gynecol pmid:5635835
Sabel GH and Kirk RF Biliary stasis after mestranol-norethindrone ingestion. Report of a case. 1968 Obstet Gynecol pmid:5639192
Kilpatrick ZM et al. Vascular occlusion of the colon and oral contraceptives. Possible relation. 1968 N. Engl. J. Med. pmid:5636665
Rubin L and Rogers A Neurological symptoms and oral contraceptives. 1968 Can Med Assoc J pmid:5641510
Watanabe H et al. Distribution of radioactivity in rat tissues after administration of tritiated 17-alpha-ethynyl-19-norsteroids. 1968 Steroids pmid:5641818
Horowitz BJ et al. The oversuppression syndrome. 1968 Obstet Gynecol pmid:5639193
Zañartu J and Navarro C Fertility inhibition by an injectable progestogen acting for 3 months. A clinical survey of 130 fertile women treated with norethisterone enanthate. 1968 Obstet Gynecol pmid:5651111
Snaith L The treatment of endometriosis by oral progestogens. 1968 Proc. R. Soc. Med. pmid:5653994
Poller L et al. Effects of low-dose oral contraceptives on blood coagulation. 1968 Br Med J pmid:5662975
Holzmann H and Korting GW [Treatment of scleroderma]. 1968 Dtsch. Med. Wochenschr. pmid:5668267
Levin W et al. Decreased uterotropic potency of oral contraceptives in rats pretreated with phenobarbital. 1968 Endocrinology pmid:5659427
DeMeere LJ et al. Cholesterol content of menstrual discharge. Influence of contraceptives. 1968 Obstet Gynecol pmid:5742478
Reyes Ceja L et al. [Therapeutic effectiveness of norethindrone-mestranol in dysfunctional uterine bleeding]. 1968 Ginecol Obstet Mex pmid:5674323
Hansson O Effect of 4-desoxypyridoxine on the initial excretion rates of 3-hydroxykynurenine and 3-hydroxyanthranilic acid after tryptophan loading. 1968 Acta Soc Med Ups pmid:5677554
Moawad AH and Bengtsson LP In vivo studies of the motility pattern of the nonpregnant human uterus. 3. The effect of anovulatory pills. 1968 Am. J. Obstet. Gynecol. pmid:5690296
Chernick BA Blood pressure and body weight changes during oral contraceptive treatment. 1968 Can Med Assoc J pmid:5686314
Seiga K [Evaluation of norethindrone combined with mestranol (S-3800 C) as an oral contraceptive]. 1968 Iryo pmid:5686370
Arras MJ and Saunders AM Renal cortical necrosis with pituitary infarction in a nonpregnant woman. 1968 Arch Pathol pmid:5689121
Wilbert L et al. [Serum enzyme activities and bromsulphalein retention due to ovulation inhibitors]. 1968 Dtsch. Med. Wochenschr. pmid:5683966
Kesseru E and Larranaga A [Mechanism of action of prolonged-action injectable contraceptives]. 1968 Ginecol Obstet (Lima) pmid:12331776
Fekete G Chemistry, pharmacology and clinical pharmacology of oral contraceptives. 1968 Ther Hung pmid:12334483
Oakley C and Somerville J Oral contraceptives and progressive pulmonary vascular disease. 1968 Lancet pmid:4171491
Mowat AP Hormonal effects on liver D-glucuronolactone dehydrogenase levels in mice. 1968 J. Endocrinol. pmid:5715982
Macaraeg PV et al. Neutrophil alkaline phosphatase activity. Effect of certain oral contraceptive hormones. 1968 Arch. Intern. Med. pmid:4176910
Kincl FA et al. Sustained release hormonal preparations. 1. Diffusion of various steroids through polymer membranes. 1968 Steroids pmid:5650692
Schatz DL et al. Effects of oral contraceptives and pregnancy on thyroid function. 1968 Can Med Assoc J pmid:4177069
Tojo S et al. [Experimental studies on the mechanism of contraceptive action of norethindrone mestranol]. 1968 Horumon To Rinsho pmid:5749762
Schally AV et al. Studies on the site of action of oral contraceptive steroids. I. Effect of antifertility steroids on plasma LH levels and on the response to luteinizing hormone-releasing factor in rats. 1968 J. Clin. Endocrinol. Metab. pmid:4177382
Kamyab S et al. Metabolism of (4-14C) norethisterone in women. 1968 J. Endocrinol. pmid:5710531
Chalmers JA Conservative management of endometriosis. 1968 Proc. R. Soc. Med. pmid:5653995
Lewis JL et al. Heterotransplantation of human choriocarcinoma in monkeys. 1968 Cancer Res. pmid:4972265
Hutcherson WP et al. Long-term evaluation of two oral contraceptives. 1967 Sep-Oct Fertil. Steril. pmid:6037450
Rice-Wray E et al. Return of ovulation after discontinuance of oral contraceptives. 1967 Mar-Apr Fertil. Steril. pmid:6020669
Greenblatt RB One-pill-a-month contraceptive. 1967 Mar-Apr Fertil. Steril. pmid:4164103
Milton MD and Nelson JH A new long dosage oral contraceptive, 1.0 mg. norethindrone. A preliminary study. 1967 Mar-Apr Pac Med Surg pmid:6039890
Sonkin R and Bordigoni R [The use of synthetic progesteroids in various psychiatric syndromes unrelated to contraceptive and gynecologic usage]. 1967 Jan-Mar Bull Fed Soc Gynecol Obstet Lang Fr pmid:5602146
London GD and Lawrence PB Alteration of postcoital examination by systemic medication. 1967 Jan-Feb Fertil. Steril. pmid:6066822
Allan JS and Tyler ET Biochemical findings in long-term oral contraceptive usage. I. Liver function studies. 1967 Jan-Feb Fertil. Steril. pmid:4163465
Connell EB et al. Endometrial enzyme histochemistry in oral contraceptive therapy. 1967 Jan-Feb Fertil. Steril. pmid:4163466
Wilson JG and Gavan JA Congenital malformations in nonhuman primates: spontaneous and experimentally induced. 1967 Anat. Rec. pmid:4382271
Taymor ML and Rizkallah TH Progestogen-estrogen therapy in the menopause. A double blind study. 1967 Am. J. Obstet. Gynecol. pmid:6016347
Bell ET and Loraine JA Urinary steroid and gonadotrophin excretion in women following long-term use of oral contraceptives. 1967 Lancet pmid:4166105
Hulka JF and Mohr K Interference of cortisone-induced homograft survival by progestins. 1967 Am. J. Obstet. Gynecol. pmid:5334310
Nicholls RA and Board JA Carbonic anhydrase concentration in endometrium after oral progestins. 1967 Am. J. Obstet. Gynecol. pmid:4969093
Voorhess ML Masculinization of the female fetus associated with norethindrone-mestranol therapy during pregnancy. 1967 J. Pediatr. pmid:5293850
Ask-Upmark E Progestin, thrombophlebitis and migraine. 1967 Acta Med Scand pmid:4951472
Larranaga Legula A and Kesseru E [Clinical experience with a prolonged-action injectable hormonal contraceptive]. 1967 Ginecol Obstet (Lima) pmid:12305606
Rakoff AE Menstrual disorders of the adolescent. 1967 Ann. N. Y. Acad. Sci. pmid:5231263
Lynn BD "The pill" as an etiologic agent in hypertrophic gingivitis. 1967 Oral Surg. Oral Med. Oral Pathol. pmid:5233379
Kabarity A and Khodary S Merokinetic effect of Anovlar. 1967 Lancet pmid:4164318
Notter G and Wicklund H [Treatment of inoperable and metastasizing breast cacinoma with gestagen hormones]. 1967 Munch Med Wochenschr pmid:5632005
Plate WP Ovarian changes after long-term oral contraception. 1967 Acta Endocrinol. pmid:6071598
Yotis WW In vivo and in vitro action of norethindrone on staphylococci. 1967 J. Bacteriol. pmid:4964476
Dodek OI and Kotz HL Syndrome of anovulation following the oral contraceptives. 1967 Am. J. Obstet. Gynecol. pmid:4951888
Brakman P et al. Blood coagulation, fibrinolysis, and contraceptive hormones. 1967 JAMA pmid:6071154
Larsson-Cohn U and Stenram U Liver ultrastructure and function in icteric and non-icteric women using oral contraceptive agents. 1967 Acta Med Scand pmid:6066986
Daly RJ et al. Psychosis associated with the use of a sequential oral contraceptive. 1967 Lancet pmid:4166106
Rudel HW et al. Assay of the anti-oestrogenic effects of progestagens in women. 1967 J. Reprod. Fertil. pmid:4164525
Benassi CA [Contraceptive drugs]. 1967 Farmaco Prat pmid:5615977
Maeda I [Mechanism of contraceptives with norethisterone and mestranol]. 1967 Nippon Sanka Fujinka Gakkai Zasshi pmid:5628444
Shroff AP and Grodsky J Comparison of an ultraviolet spectrophotometric assay and a gas-liquid chromatographic assay for 17-alpha-ethynylestradiol 3-methyl ether in tablets. 1967 J Pharm Sci pmid:6034541
Zussman WV et al. Ovarian morphology following cyclic norethindrone-mestranol therapy. 1967 Am. J. Obstet. Gynecol. pmid:6034978
Nilsson L and Sölvell L Clinical studies on oral contraceptives--a randomized, doubleblind, crossover study of 4 different preparations (Anovlar mite, Lyndiol mite, Ovulen, and Volidan). 1967 Acta Obstet Gynecol Scand pmid:4229036
Kaern T Effect of an oral contraceptive immediately post partum on initiation of lactation. 1967 Br Med J pmid:6038336
Rivoire J [Apropos of the appearance of chloasma during treatment with synthetic progestational agents]. 1967 Lyon Med pmid:6042243
Nickerson CW and Berkman VO Lactation inhibition by norethindrone with mestranol. 1967 Rocky Mt Med J pmid:6044157
Dudley B Treatment of the artificial menopause. 1967 Practitioner pmid:6047166
Cowan LE Clinical evaluation of a new sequential oral contraceptive agent. 1967 Can Med Assoc J pmid:6022790
Callantine MR et al. Action of progesterone ans synthetic progestogens on estrogen-induced ovarian growth. 1967 Proc. Soc. Exp. Biol. Med. pmid:6023395
di Paola G et al. Effects of oral contraceptives. 1967 Lancet pmid:4164807
Taylor HB et al. Atypical endocervical hyperplasia in women taking oral contraceptives. 1967 JAMA pmid:6072808
Kamyab S et al. Metabolism and tissue distribution of norethisterone and norgestrel in rabbits. 1967 J. Endocrinol. pmid:6073668
Kawakami M and Sawyer CH Effects of sex hormones and antifertility steroids in brain thresholds in the rabbit. 1967 Endocrinology pmid:4164655